5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.40▲ | 6.47▼ | 6.45▼ | 7.13▼ | 7.22▼ |
MA10 | 6.42▲ | 6.44▲ | 6.57▼ | 7.07▼ | 7.46▼ |
MA20 | 6.44▲ | 6.64▼ | 6.87▼ | 7.32▼ | 7.84▼ |
MA50 | 6.53▼ | 7.11▼ | 7.18▼ | 7.49▼ | 7.01▼ |
MA100 | 6.83▼ | 7.09▼ | 7.04▼ | 7.80▼ | 9.23▼ |
MA200 | 7.16▼ | 7.26▼ | 7.60▼ | 7.52▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.009▲ | 0.011▲ | -0.049▼ | -0.031▼ | -0.171▼ |
RSI | 49.085▼ | 35.599▼ | 32.142▼ | 36.142▼ | 44.292▼ |
STOCH | 36.627 | 39.118 | 13.083▼ | 57.125 | 30.018 |
WILL %R | -26.667 | -81.356▼ | -87.209▼ | -85.256▼ | -91.510▼ |
CCI | 9.485 | -59.838 | -80.732 | -61.324 | -92.711 |
Thursday, December 05, 2024 11:59 PM
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) has received a consensus rating of “Buy” from the six research firms that are currently covering the firm, MarketBeat.com reports. Six ...
|
Thursday, December 05, 2024 11:59 PM
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) has received a consensus rating of “Buy” from the six research firms that are currently covering the firm, MarketBeat.com reports. Six ...
|
Wednesday, November 27, 2024 08:00 AM
– Positive clinical data with confirmed overall response rate (ORR) = 62.5% (95% CI, 30.4-86.5) and prospective ACR-368 OncoSignature patient selection (p = 0.009) from ongoing ACR-368 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
05/12/24 | 6.87 | 6.97 | 6.34 | 6.44 | 72,451 |
04/12/24 | 7.35 | 7.35 | 6.70 | 6.73 | 88,636 |
03/12/24 | 7.37 | 7.45 | 7.063 | 7.45 | 74,050 |
02/12/24 | 7.67 | 7.82 | 7.36 | 7.44 | 77,582 |
29/11/24 | 7.56 | 7.69 | 7.56 | 7.58 | 20,198 |
27/11/24 | 7.46 | 7.70 | 7.21 | 7.52 | 51,142 |
26/11/24 | 7.27 | 7.5257 | 7.17 | 7.35 | 27,516 |
25/11/24 | 6.61 | 7.21 | 6.61 | 7.16 | 84,319 |
22/11/24 | 6.45 | 6.634 | 6.33 | 6.55 | 25,934 |
21/11/24 | 6.50 | 6.68 | 6.43 | 6.44 | 27,283 |
|
|
||||
|
|
||||
|
|